Your browser doesn't support javascript.
loading
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Appelbaum, Jacob S; Wei, Andrew H; Mandrekar, Sumithra J; Tiong, Ing S; Chua, Chong Chyn; Teh, Tse-Chieh; Fong, Chun Yew; Ting, Stephen B; Weber, Daniela; Benner, Axel; Hill, Hannah; Saadati, Maral; Yin, Jun; Stone, Richard M; Garcia-Manero, Guillermo; Erba, Harry P; Uy, Geoffrey L; Marcucci, Guido; Larson, Richard A; Thomas, Abin; Freeman, Sylvie D; Almuina, Nuria Marquez; Döhner, Konstanze; Thomas, Ian; Russel, Nigel H; Döhner, Hartmut; Othus, Megan; Estey, Elihu H; Walter, Roland B.
Afiliação
  • Appelbaum JS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Wei AH; Division of Hematology and Oncology, University of Washington, Seattle, WA, USA.
  • Mandrekar SJ; Seattle Children's Therapeutics, Seattle Children's Hospital, Seattle, WA, USA.
  • Tiong IS; Department of Clinical Haematology, Peter MacCallum Cancer Centre, and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Chua CC; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Teh TC; Department of Quantitative Health Sciences, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
  • Fong CY; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ting SB; The Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
  • Weber D; Australasia Leukaemia and Lymphoma Group (ALLG), Richmond, VIC, Australia.
  • Benner A; The Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
  • Hill H; Australasia Leukaemia and Lymphoma Group (ALLG), Richmond, VIC, Australia.
  • Saadati M; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Yin J; Department of Haematology, Northern Hospital, Melbourne, VIC, Australia.
  • Stone RM; The Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
  • Garcia-Manero G; Department of Haematology, Eastern Health, Box Hill, VIC, Australia.
  • Erba HP; Austin Health, Melbourne, VIC, Australia.
  • Uy GL; Eastern Health, Box Hill Hospital and Monash University, Melbourne, VIC, Australia.
  • Marcucci G; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
  • Larson RA; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Thomas A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Freeman SD; Freelance Statistician, Saadati Solutions, Ladenburg, Germany.
  • Almuina NM; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Döhner K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Thomas I; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
  • Russel NH; Duke University Cancer Center, Durham, NC, USA.
  • Döhner H; Washington University School of Medicine, St. Louis, MO, USA.
  • Othus M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Estey EH; University of Chicago, Chicago, IL, USA.
  • Walter RB; Centre for Trials Research, Cardiff University, Cardiff, UK.
Leukemia ; 38(2): 389-392, 2024 02.
Article em En | MEDLINE | ID: mdl-38263433
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article